GTS Securities’s Astera Labs ALAB Stock Holding History

GTS Securities’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,900	Closed	-$1.62M	–	4396
2024 Q1	$1.62M	Buy	+21,900	New	+$1.62M	﹤0.01%	1614

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

GTS Securities's ALAB Position: Q1 2026 in Review

GTS Securities sold out of Astera Labs (ALAB) in Q1 2026, closing a stake of 11,584 shares — an estimated $1.93M sold.

GTS Securities first reported a position in ALAB in Q1 2024 and held it in 3 quarters. The position peaked at $1.93M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

GTS Securities reported no remaining Astera Labs position as of Q1 2026 after selling out during the quarter.
GTS Securities sold 11,584 Astera Labs shares in Q1 2026, an estimated $1.93M.
GTS Securities first reported a position in Astera Labs in Q1 2024 and held it in 3 quarters.
GTS Securities's Astera Labs position peaked at $1.93M in Q4 2025.
703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.